Pfizer and BioNTech Receive U.S. FDA Approval for XFG-adapted COVID-19 Vaccine
Go back to Pfizer and BioNTech Receive U.S. FDA Approval for XFG-adapted COVID-19 Vaccine| (NASDAQ: BNTX) | Delayed: 98.66 -5.1 (4.92%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $103.76 | 52 Week High | $ | |||
| Open | $100.24 | 52 Week Low | $ | |||
| Day High | $101.33 | P/E | N/A | |||
| Day Low | $98.18 | EPS | $ | |||
| Volume | 1,127,491 | |||||
